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It would be ideal to evaluate this hypothesis by a
prospective randomized trial. It is unclear whether such a
trial is a realistic possibility. Our data provide a level of
comfort that CABG patients with asymptomatic carotid
stenosis can be offered combined CEA-CABG without
undue risk of increased perioperative stroke, myocardial
infarction, or death. This may encourage clinicians to enter
patients into a future randomized study.
Meanwhile, our data give reassurance to clinicians who
currently recommend combinedCEA-CABG topatientswith
simultaneous surgical lesions in both circulations. Further-
more, these data lend support to the practice of screening
patients with coronary disease for carotid stenosis prior to
cardiac intervention. Although such patients are at increased
risk for coronary surgery, our data suggest that they can
reasonably be offered a combined surgical approach.
Finally, these data are relevant to the question of ca-
rotid stenting in patients who are to undergo CABG. The
major goals of carotid stenting include avoiding open sur-
gery and reducing periprocedural morbidity. The first goal
is not obtainable in patients who are to undergo CABG.
Our data suggest that to be of true clinical and economic
benefit in this patient group, carotid stenting would need
to reduce the risk of stroke in this patient group compared
with CABG alone. It is possible that as percutaneous tech-
niques for coronary and carotid revascularization improve,
a comparison of all percutaneous and all open revascular-
ization will be appropriate.
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INVITED COMMENTARY
Bruce A. Perler, MD, MBA, Baltimore, Md
Although at least 50 articles have appeared in the peer-
reviewed literature over the last three decades documenting the
results of combined coronary bypass grafting (CABG) and carotid
endarterectomy (CEA), a consensus on the most appropriate man-
agement of severe coexistent coronary and carotid artery occlusive
disease remains unsettled, and this is partly due to high rates of
perioperative complications after synchronous CABG/CEA.
Unfortunately, the published experience in this area almost
exclusively consists of retrospective reports and anecdotal case
series. The only randomized, single-center trial was published
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more than 15 years ago, and it is unlikely that a comprehensive
multicenter investigation of this issue will be undertaken. In the
absence of level 1 evidence, therefore, the current study using
case-controlled methodology with propensity testing to achieve
risk stratification represents the next best alternative to a random-
ized clinical trial and is an important contribution.
It is estimated that 6% to 16% of CABG candidates harbor
significant carotid disease. In a screening study of 1421 consecu-
tive CABG patients at the Johns Hopkins Hospital during the last
2 years, for example, the incidence of a 70% unilateral internal
carotid stenosis was 13.4% and that for bilateral70% stenoses was
3.5%.1
With the growth of drug-eluting coronary stents and the
associated reduction in the performance of surgical coronary revas-
cularization, CABG is today performed upon individuals with the
most severe, multivessel, coronary disease. Furthermore, at the
Johns Hopkins Hospital, like many other centers, we are preferen-
tially staging the CEA and CABG by 1 or 2 days in most cases
rather than carrying out a solitary combined procedure.1 There-
fore, the patient population undergoing synchronous CABG/
CEA in practice today has the most severe systemic atherosclerosis
in whom one would logically anticipate the highest rate of periop-
erative neurologic and other complications after combined
CABG/CEA.
In the absence of a comprehensive, randomized, prospective
clinical trial, however, it has not been possible to ascribe the
generally higher rate of complications after these synchronous
procedures to patient comorbidity rather than the inherent risk of
the synchronous surgery. However, this study provides compelling
evidence that when one controls for comorbidity levels, adding a
CEA to a CABG does not increase operative risk!
Stroke remains one of the most devastating complications of
cardiac surgery, and significant carotid artery disease is one poten-
tial etiology that can be identified preoperatively and surgically
prevented. Although the current investigation does not prove that
combined CEA/CABG reduces that risk and suffers from some
limitations, such as not controlling for individual center or surgeon
case volume, or selection criteria that may vary from center to
center in New York state, it strongly suggests that a CEA can be
performed at the time of CABG without increasing operative risk
over that of CABG alone. Furthermore, as CEA remains the
gold-standard treatment for significant carotid disease, these data
provide no support for the notion that carotid stenting would be a
more appropriate intervention in the patient population with sig-
nificant coexistent carotid and coronary disease.
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